Related Experiment Video
Updated: Apr 28, 2026

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices
Published on: August 1, 2025
Obscure recurrent gastrointestinal bleeding: a revealed mystery?
Maria Elena Riccioni1, Riccardo Urgesi, Rossella Cianci
1Digestive Endoscopy Unit, Catholic University of Rome , Rome , Italy.
Insights
Capsule endoscopy (CE) can identify upper or lower gastrointestinal bleeding sources missed by conventional endoscopy in about 28% of obscure gastrointestinal bleeding (OGIB) cases. This highlights CE
Area of Science:
- Gastroenterology
- Endoscopy
- Diagnostic Imaging
Background:
- Capsule endoscopy (CE) is the primary diagnostic tool for obscure gastrointestinal bleeding (OGIB) after negative upper and lower gastrointestinal (GI) endoscopy.
- A significant proportion of patients undergoing CE for OGIB have bleeding sources located in the stomach or colon, not just the small bowel.
- Identifying missed lesions from conventional endoscopy is crucial for effective patient management in OGIB.
Purpose of the Study:
- To determine the incidence of bleeding lesions in the upper or lower GI tract that were missed by prior gastroscopy and colonoscopy.
- To evaluate the utility of CE in detecting these missed lesions in patients with obscure GI bleeding.
- To assess the indications for repeating comprehensive endoscopic workup in patients with obscure bleeding before CE.
Main Methods:
- Prospective review of data from 637 patients who underwent CE for obscure bleeding at a tertiary center.
- All patients had previously negative gastroscopy and colonoscopy examinations.
- Analysis focused on lesions identified by CE located outside the small bowel.
Main Results:
- CE identified a cause of bleeding in the stomach in 21.7% (138/637) and in the colon in 6.4% (41/637) of patients with prior negative endoscopies.
- Lesions outside the small bowel were detected in 8.5% (54/637) of patients.
- In patients with upper/lower GI lesions, CE also frequently identified small-bowel abnormalities, and all patients received appropriate therapy.
Conclusions:
- Approximately 28% of patients with obscure bleeding have upper or lower GI lesions missed by conventional endoscopy.
- Capsule endoscopy plays a vital role in uncovering these missed lesions, improving diagnostic yield in OGIB.
- CE can guide further endoscopic interventions or surgical management for non-small bowel lesions.
Objective:
Nowadays, capsule endoscopy (CE) is the first-line procedure after negative upper and lower gastrointestinal (GI) endoscopy for obscure gastrointestinal bleeding (OGIB). Approximately, two-thirds of patients undergoing CE for OGIB will have a small-bowel abnormality. However, several patients who underwent CE for OGIB had the source of their blood loss in the stomach or in the colon. The aim of the present study is to determine the incidence of bleeding lesions missed by the previous gastroscopy/colonoscopy with CE and to evaluate the indication to repeat a new complete endoscopic workup in subjects related to a tertiary center for obscure bleeding before CE.
Methods And Methods:
We prospectively reviewed data from 637/1008 patients underwent to CE for obscure bleeding in our tertiary center after performing negative gastroscopy and colonoscopy.
Results:
CE revealed a definite or likely cause of bleeding in stomach in 138/637 patients (yield 21.7%) and in the colon in 41 patients (yield 6.4%) with a previous negative gastroscopy and colonoscopy, respectively. The lesions found were outside the small bowel in only 54/637 (8.5%) patients. In 111/138 patients, CE found lesions both in stomach and small bowel (small-bowel erosions in 54, AVMs in 45, active small-bowel bleeding in 4, neoplastic lesions in 3 and distal ileum AVMs in 5 patients). In 24/41 (58.5%) patients, CE found lesions both in small bowel and colon (multiple small-bowel erosions in 15; AVMs in 8 and neoplastic lesion in 1 patients. All patients underwent endoscopic therapy or surgery for their nonsmall-bowel lesions.
Conclusions:
Lesions in upper or lower GI tract have been missed in about 28% of patients submitted to CE for obscure bleeding. CE may play an important role in identifying lesions missed at conventional endoscopy.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Esophageal Varices-I: Introduction
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Introduction
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
